MyJournals Home  

RSS FeedsCD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia (Leukemia)

 
 

21 may 2019 08:00:08

 
CD22 CAR T-cell therapy in refractory or relapsed B acute lymphoblastic leukemia (Leukemia)
 




 
84 viewsCategory: Pathology
 
Aeromonas sobria peritonitis in a peritoneal dialysis (PD) patient: a case report and review of the literature (BMC Nephrology)
Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma (Leukemia)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten